Duopharma Biotech invests RM2.06mil in local digital service provider

KUALA LUMPUR: Duopharma Biotech Bhd will invest US$500,000 (RM2.06mil) in a local digital health service provider via a Series A funding round to expand its smart digital integrated health applications.

The investment in Naluri Hidup Sdn Bhd, which is a local pioneer in digital therapeutics, follows Duopharma’s initial investment of US$250,000 in the company for a personalised digital holistic healthcare application.

Duopharma said in a statement that its investment along with that of other international and local venture capital firms, will enable Naluri to expand operations into the region and deepen its data science capabilities.

It added that the partnership will enable it to deliver evidence-based therapeutic interventions using Naluri’s digital therapeutics solution, which is designed to help people manage their chronic disease risks through structured multi-disciplinary behavioural and psychological coaching programmes.

According to Duopharma, effective use of holistic therapeutics could double the healthcare effectiveness when compared to a purely pharmacotherapeutic (medication

only) approach, and could also be four times more cost-efficient and increase accessibility to clinicians and other health and fitness experts online as well.

“The smart application of digital technologies to enhance the effectiveness of healthcare and achieve the objective of a healthier life for all is one of Duopharma Biotech’s strategic pillars.

“We are proud to be part of this latest milestone to empower homegrown health technologies,” said Duopharma group managing director Leonard Ariff Abdul Shatar.